Like caffeine, pharmacological and genetic A2AR blockade was found to reduce hippocampal pathology, neuroinflammation and memory deficits in a model of AD-like Tau pathology (Laurent et al., 2016). This evidence concerns the gene ADORA2A and Alzheimer disease.